Amount Raised
$12.7 Million
Round Type
series b
Description
Metcela Inc., a clinical-stage biotech startup specializing in fibroblast-based cell therapy, has raised $12.7 million in Series B funding.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech